Nektar Therapeutics (NASDAQ:NKTR)

48.31
BATS BZX Real-Time Price
As of 12:57pm ET
 -0.77 / -1.57%
Today’s Change
17.51
Today|||52-Week Range
111.36
-19.11%
Year-to-Date

Today’s Trading

Previous close49.08
Today’s open48.94
Day’s range47.98 - 49.17
Volume55,082
Average volume (3 months)4,114,245
Market cap$8.2B
Data as of 12:57pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)+701.94%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book86.97

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-0.54-0.66%
----
XONIntrexon Corp+0.04+0.27%
BPMCBlueprint Medicines ...-0.37-0.58%
Data as of 12:57pm ET, 07/20/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$5.22
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts